Results 101 to 110 of about 22,370 (168)

Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review. [PDF]

Diabetes Metab Syndr Obes
Puspitasari IM, Putra DS, Deliyana AN, Adiputri NI, Octovia LI, Paramita SA, Sinuraya RK.   +6 more
europepmc   +1 more source

Adaptive islet biology and comprehensive incretin physiology: Emerging perspectives from Asia and Europe. [PDF]

J Diabetes Investig
Murakami T, Nasteska D, Hodson DJ, Yamazaki Y, Yabe D, Seino Y.   +5 more
europepmc   +1 more source

Clinical Potential of GIP in Type 2 Diabetes and Obesity. [PDF]

Diabetes Care
Nauck M, Gribble F, Reimann F, D'Alessio DA, Campbell JE.   +4 more
europepmc   +1 more source

Weight loss and cardiovascular outcomes with incretin-based therapies after metabolic and bariatric surgery: a nationwide US cohort study. [PDF]

EClinicalMedicine
Gillikin A, Lee Y, Varney C, Dang JT, Tsung A, Nimeri A, Shin TH.   +6 more
europepmc   +1 more source

The Effects of Incretin Mimetic Therapies on Muscle and Bone Health in Older Adults: A Narrative Review. [PDF]

Obesity (Silver Spring)
Saavedra JM, Chen AS, Porter Starr KN, Batsis JA.   +3 more
europepmc   +1 more source

Editorial: Incretin-based therapies in the treatment of metabolic syndrome: expanding roles beyond weight management

Frontiers in Endocrinology
Kexin Zhang, Kexin Zhang, Xiaodong Sun, Xiaodong Sun, Lixin Li   +4 more
doaj   +1 more source

Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study. [PDF]

PLoS One
Kazi MAI, Mufarrih SM, Sirohi A, Hasan F, Sharma A, Singh S, Muganlinskaya N, Haq N.   +7 more
europepmc   +1 more source

Incretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications-A Narrative Review. [PDF]

Int J Mol Sci
La Vignera S, Condorelli RA.
europepmc   +1 more source

Beyond Weight Loss: Tirzepatide as a Metabolic Disease-Modifying Strategy for Metabolic Dysfunction-Associated Steatohepatitis: A Narrative Review. [PDF]

Health Sci Rep
Ahmed Z, Mustafa N, Sarkar T, Yasmin H.
europepmc   +1 more source